CompletedNot Applicable

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients

France29 participantsStarted 2008-03

Plain-language summary

This prospective study evaluate the immune status of patients admitted in ICU.CMV remains dormant in the body, but in people with immune deficiency, CMV could reactivate and cause life-threatening pneumonia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age more than 18-year-old * Informed consent Exclusion Criteria: * minors, * pregnant or lactating women, * adults under guardianship, * immunosuppression at the entrance to resuscitation, * AIDS

What they're measuring

Bring to light the quantitative and qualitative immunological modifications of the present cells NK before the arisen of an infection to CMV

Timeframe: 24 months

Trial details

NCT IDNCT00699868

SponsorAssistance Publique Hopitaux De Marseille

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-01

View on ClinicalTrials.gov More Cytomegalovirus Infection trials